- Research article
- Open Access
- Open Peer Review
Inoculation with enterococci does not affect colon inflammation in the multi-drug resistance 1a-deficient mouse model of IBD
© Barnett et al. 2016
- Received: 5 August 2015
- Accepted: 24 February 2016
- Published: 3 March 2016
Intestinal bacteria are thought to play a role in the pathogenesis of human inflammatory bowel disease (IBD). We investigated whether oral inoculation with specific intestinal bacteria increased colon inflammation in the multi-drug resistance 1a-deficient (Mdr1a –/– ) mouse model of IBD.
Five-week-old Mdr1a –/– mice (FVB background) and FVB mice were randomly assigned to one of two treatment groups (Control or Inoculation, n = 12 per group). All mice were fed AIN-76A rodent diet, and mice in the Inoculation groups also received a single oral bacterial inoculation consisting of twelve cultured Enterococcus species combined with conventional intestinal flora obtained from the gastrointestinal tract of healthy mice (EF.CIF). Body weight, food intake, and disease activity index (DAI) were assessed throughout the study, and at 21 or 24 weeks of age, inflammation was assessed post-mortem by determining colon length and histological injury score (HIS), and plasma serum amyloid A (SAA).
Mdr1a –/– mice consumed more food than FVB mice at 13 weeks of age (P < 0.05). There was also a significant effect of genotype on body weight, with Mdr1a –/– mice weighing less than FVB mice throughout the study (P < 0.05) regardless of treatment, but there was no effect of inoculation on body weight (P > 0.25). Colon HIS of Mdr1a –/– mice was significantly higher than that of FVB mice in the Control (9.3 ± 4.7 (mean ± SD) vs. 0.58 ± 0.51; P < 0.001) and Inoculation (6.7 ± 5.1 vs. 0.92 ± 0.39; P < 0.001) groups. There was no difference in colon HIS of Mdr1a –/– mice in the Control group compared with Mdr1a –/– mice in the Inoculation group (P = 0.25), nor was there any difference in within-group variation of colon HIS in these two Mdr1a –/– groups. DAI was higher in Mdr1a –/– mice than in FVB mice, but there was no effect of treatment in either strain, nor were there any differences in colon length or plasma SAA.
Inoculation of Mdr1a –/– mice with the EF.CIF inoculum described here does not increase colon inflammation or reduce the observed variability of inflammation.
- Multiple drug resistance
- Inflammatory bowel disease
- Serum amyloid A protein
Crohn’s disease (CD) and ulcerative colitis (UC) are collectively known as inflammatory bowel disease (IBD), and are characterised by chronic inflammation of the gastrointestinal (GI) tract. Although the aetiology of IBD is still not clear, there is strong evidence to suggest that dysregulated mucosal immune responses to commensal intestinal microbiota in genetically susceptible individuals are a key factor .
Small animal models of intestinal inflammation are useful to better characterize the mechanisms underlying human IBD. The multi-drug resistance 1a (Mdr1a) gene (also known as the Abcb1a gene) encodes a membrane drug-efflux pump that is expressed in intestinal epithelial cells, as well as in other cell types. The disruption of this gene in Mdr1a –/– mice results in spontaneous inflammation in the colon which exhibits a pathology similar to that of human IBD , making them a relevant and appropriate animal model with which to study IBD . However, ours and other studies with this mouse model have shown that the time of onset and severity of inflammation in Mdr1a –/– mice are variable [2, 4].
We have previously used oral bacterial inoculation with Enterococcus species and intestinal flora from conventionally raised mice (collectively referred to as EF.CIF) to establish more consistent inflammation in the interleukin 10 gene-deficient (Il10 –/– ) mouse model of IBD . Because there is evidence that commensal bacteria play a role in the intestinal inflammation seen in Mdr1a –/– mice [6, 7], in the current study the hypothesis that oral inoculation with the EF.CIF inoculum could induce increased and/or more consistent inflammation in Mdr1a –/– mice was tested.
This study was carried out in accordance with the recommendations of the New Zealand Animal Welfare Act 1999. The experimental procedures for this study were reviewed and approved by the AgResearch Grasslands Animal Ethics Committee in Palmerston North, New Zealand (Ethics Application No.: 10712). All efforts were made to minimize animal suffering.
Animals and diet
This study was part of a larger investigation on the effects of dietary polyphenols in the Mdr1a –/– mouse model of IBD (see Additional file 1). The “Control” groups for both Mdr1a –/– and FVB mice were therefore used as dietary controls for the previously reported investigations of dietary polyphenols [6, 8]. For this study on the effects of bacterial inoculation, twenty-four male Mdr1a –/– mice (FVB.129P2-PAbcb1a tm1Bor N7) and 24 male FVB/NTac mice (subsequently referred to as FVB mice, with the same background strain as the Mdr1a –/– mice) were purchased from Taconic (Hudson, NY, USA) at 5-6 weeks of age. The mice were individually housed in shoebox-style cages containing untreated wood shavings (Cairns Bins, Palmerston North, New Zealand (NZ)) with a plastic tube for environmental enrichment. The animal room was controlled and maintained at a temperature of 22 °C, humidity of 60 % and a 12/12 h light/dark cycle. All mice were given free access to water and offered a standard chow diet ad libitum. After 1 week of acclimatization on this chow diet (i.e., at approximately 7 weeks of age), both Mdr1a –/– and FVB mice were randomly assigned to one of two intervention groups (n = 12 per group); an AIN-76A powdered diet prepared in-house as previously described  (Control group); or the AIN-76A diet + a single oral inoculation with 200 μL of a mixture of Enterococcus faecalis and E. faecium cultures plus complex intestinal flora (collectively referred to as EF.CIF; Inoculation group) . Each mouse received a dose of approximately 6 x 107 CFU from the Enterococcus cultures. Details of the bacterial inoculation protocol, and information regarding the twelve Enterococcus strains used (which were exactly the same as in our previous studies using Il10 –/– mice), have already been reported . Fresh diets were fed ad libitum and food consumption was recorded in week 8 (14–15 weeks of age) and week 11 (17–18 weeks of age) of the intervention period to measure the average food intake. Mice were weighed three times a week and visually checked daily for the presence of loose stools, blood in faeces, or decreased mobility (the disease activity index; DAI) which has been reported to correlate with intestinal inflammation . DAI data were recorded at least once a week, and a total DAI score at each time was calculated for each mouse based on the combined scores of weight loss, stool consistency, rectal bleeding and mobility (each ranging from 0 to 4), divided by 4.
Food intake and body weight data for FVB and Mdr1a –/− mice fed an AIN-76A diet (Control), or fed an AIN-76A diet and orally inoculated with a single dose of a mixture of Enterococcus faecalis and E. faecium cultures and complex intestinal flora (EF.CIF; Inoculation)
Number of micea
Food intakeb (15 weeks of age)
Food intakeb (18 weeks of age)
Body weight (7 weeks of age; start of intervention)c
Body weight (19 weeks of age: after 12 weeks of treatment)c
Fasted body weight before samplingd
(21 or 24 weeks of age)
4.5 ± 0.8
4.7 ± 0.5
24.8 ± 1.6
37.1 ± 5.3
34.4 ± 6.0
4.4 ± 0.6
4.7 ± 0.4
24.7 ± 1.1
37.6 ± 2.5
36.0 ± 4.0
Mdr1a –/– mice
4.7 ± 0.2
4.3 ± 1.0
23.6 ± 1.5
30.8 ± 4.3
28.2 ± 4.5
4.8 ± 0.4
4.5 ± 0.5
23.3 ± 1.6
31.4 ± 4.3
28.6 ± 5.0
Colon inflammation was assessed according to criteria which have previously been described in detail [4, 11]. Briefly, formalin-fixed colon tissue samples were processed and sectioned (4 μm), stained with haematoxylin and eosin, and assessed under a light microscope by one researcher blinded to the treatments. Each section was evaluated for the presence of inflammatory lesions, tissue destruction, and tissue repair, and a histological injury score (HIS) assigned based on this evaluation.
Serum amyloid A analysis
The level of serum amyloid A (SAA) in plasma of Mdr1a –/– mice was measured to assess systemic inflammation levels and to complement the colonic HIS data. Ten μL of plasma (diluted 1:5000) was used to measure the plasma concentration of SAA using the Serum Amyloid A kit (Tridelta Development Limited, Maynooth, County Kildare, Ireland) as described by the manufacturer.
Unless otherwise stated data are presented as mean ± standard deviation. Statistical analyses of body weight, food intake, histology, total DAI, and SAA data were by ANOVA using GenStat for Windows (version 17, VSN International Ltd, UK). The colon HIS data were log transformed as log10(Colon HIS + 0.5) and SAA as log10(SAA + 0.005) for analysis, to stabilize the variance. DAI data over time were analysed using a repeated measures ANOVA which applies a Greenhouse-Geisser adjustment (GenStat v17). Correlation analyses (Pearson product–moment correlation) to investigate the relationship between colon HIS and body weight were performed using R version 3.0.1.
Animal food intake, body weight, and disease activity index
The mean food intake at 15 weeks of age in Mdr1a –/– mice was significantly (P = 0.03) higher than that of FVB mice (Table 1). There were no significant strain differences in mean food intake at 18 weeks of age, and there was no effect of intervention (Control vs. Inoculation) at either 15 or 18 weeks (Table 1).
Mdr1a –/– mice weighed less than FVB mice throughout the study regardless of treatment (Table 1). There was no effect of inoculation on body weight for either Mdr1a –/– or FVB mice (P > 0.25; Table 1).
DAI over time, and mean total DAI, were higher in Mdr1a –/– mice than in FVB mice (P < 0.001). Mean total DAI in the Control Mdr1a –/– mice (0.13 ± 0.14) was higher than that in Control FVB mice (0.05 ± 0.04), and the same pattern was seen in animals from the Inoculation groups (Mdr1a –/– 0.12 ± 0.12 vs. FVB 0.03 ± 0.03). There was no significant effect of inoculation on mean total DAI (P = 0.8).
Colon length and histology, and plasma serum amyloid A
There was no significant effect of inoculation on mean plasma levels of SAA in Mdr1a –/– mice (Inoculated mice 0.39 ± 0.72 μg/ml vs. Control mice 0.51 ± 0.66 μg/ml; P = 0.5).
Correlations between colon HIS and body weight
Oral inoculation with the mixture of intestinal bacteria including Enterococcus isolates described here (EF.CIF) has previously been shown to increase colon inflammation in Il10 –/– mice , but this particular inoculum was not effective in Mdr1a –/– mice. This may be due to several factors, including (1) the particular strains of enterococci used, (2) differences in the pathways of inflammation between the two mouse models, (3) differences in the background mouse strain used, or (4) because the effects of specific bacterial strains or bacterial-associated antigens may be dependent on the genetic basis of the inflammation . For example, infection of Mdr1a –/– mice with Helicobacter bilis has been shown to accelerate the onset of colitis, whereas infection with H. hepaticus delayed colitis development . In contrast, both of these Helicobacter isolates have repeatedly induced severe inflammation in Il10 –/– mice . Likewise, although the EF.CIF inoculum used in the current study increased colon inflammation in Il10 –/– mice , different strains of enterococci show varying effects in this mouse model. For example, treatment of Il10 –/– mice with E. faecium NCIMB 10415 (which reduces diarrhoea in animals and in human study subjects) led to a moderate reduction of inflammation in the caecum, but had no effect on the colon . In contrast, the E. faecalis strain OG1RF is colitogenic, and production of a metalloprotease, GelE, by this strain appears to impair epithelial barrier integrity, thereby contributing to inflammation, in Il10 –/– mice . Finally, we are aware that the FVB/NJ mouse strain fails to secrete complement 5 , a factor known to exacerbate IBD in the dextran-sulfate sodium (DSS) model , and is thus partially immunocompromised. Because the Mdr1a –/– mutation was on the FVB strain, this may in part explain the lack of response in this experiment when compared with prior studies using the same inoculation protocol in the Il10 –/– mouse model, which were on a C57Bl/6 background. Furthermore, in our original study in which we reported the effect of inoculation in Il10 –/– mice, there was little evidence of inflammation in the absence of inoculation [5, 11], whereas in our original Mdr1a –/– mouse study there was clear evidence of inflammation in un-inoculated mice, although the level was variable . This suggests that the involvement of bacteria is critical for triggering inflammation in Il10 –/– mice but not in the Mdr1a –/– mouse.
In the absence of any data on the intestinal microbial populations in the current study it is not possible to draw any conclusions on the role of these populations in inflammation. However, we have previously suggested that in Il10 –/– mice, inoculation with exogenous bacteria triggers the immune response and consequently inflammation, which is followed by dysbiosis which may act to perpetuate and amplify the inflammatory response . It is tempting to speculate that in Mdr1a –/– mice some degree of dysbiosis is already present, thus limiting any effect of the introduction of additional bacteria. Obviously additional experiments in which intestinal microbial populations are assessed would be necessary to confirm this suggestion.
The lack of correlation between colon HIS and body weight in Mdr1a –/– mice (in either the Control or Inoculation groups) suggests that the reduced body weight observed in Mdr1a –/– mice is at least in part due to a metabolic alteration, rather than being entirely to disease severity per se.
One potentially important limitation of the current study is the lack of a positive control (for example, the inclusion of a group of Il10 –/– mice) to demonstrate that the inoculation per se was effective. While this type of control would be appropriate for any future studies, we do not consider it practicable to repeat the experiment with such a control. However, we are confident that in this case the bacteria (at least the Enterococcus isolates) were viable when administered. To assess the colony forming units within the volume of inoculum administered to each mouse, each Enterococcus isolate was cultured on appropriate media. Each sub-sample for this assessment was taken from the respective Enterococcus culture used for inoculation at the time that the inoculum was administered. In all twelve cases, the cultures grew successfully, which we believe demonstrates that the bacteria were viable when administered to the mice. Although we do not have similar information for the CIF component of the inoculum, this was prepared as described for our previously reported Il10 –/– mouse studies, in which we have shown consistent inflammation in response to this inoculation protocol [11, 19–21].
Inoculation of Mdr1a –/– mice with an EF.CIF inoculum (which was previously shown to increase inflammation in Il10 –/– mice) did not increase colon inflammation or reduce the observed variability of inflammation as assessed by histological and plasma SAA analyses. This result reflects the complex interactions between the intestinal bacterial population and the intestinal epithelium, and the role that the host’s genetic background may play in these interactions.
The authors acknowledge the important contributions of Sheridan Martell and Hannah Smith (Plant & Food Research) for assistance with the animal experiment; Harold Henderson (AgResearch Limited) for assistance with statistical analysis; Kim Oden (AgResearch Limited) for assistance with SAA analyses, and Adrian Cookson (AgResearch Limited) for providing the Enterococcus strains, and advice regarding the preparation of the EF.CIF inoculum. This work was largely funded by the New Zealand Ministry of Business, Innovation & Employment (MBIE), through the Nutrigenomics New Zealand programme (Contract Nos.: C02X0403, C11X1009).
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491(7422):119–24. doi:10.1038/nature11582.View ArticlePubMedPubMed CentralGoogle Scholar
- Panwala CM, Jones JC, Viney JL. A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. J Immunol. 1998;161(10):5733–44.PubMedGoogle Scholar
- Wilk JN, Bilsborough J, Viney JL. The mdr1a-/- mouse model of spontaneous colitis: a relevant and appropriate animal model to study inflammatory bowel disease. Immunol Res. 2005;31(2):151–9. doi:10.1385/IR:31:2:151.View ArticlePubMedGoogle Scholar
- Dommels YEM, Butts C, Zhu ST, Davy M, Martell S, Hedderly D, et al. Characterization of inflammation in mdr1a-/- mice and identification of related gene expression changes in colonic epithelial cells. Genes Nutr. 2007;2(2):209–23.View ArticlePubMedPubMed CentralGoogle Scholar
- Barnett MP, McNabb WC, Cookson AL, Zhu S, Davy M, Knoch B, et al. Changes in colon gene expression associated with increased colon inflammation in interleukin-10 gene-deficient mice inoculated with Enterococcus species. BMC Immunol. 2010;11:39. doi:10.1186/1471-2172-11-39.View ArticlePubMedPubMed CentralGoogle Scholar
- Nones K, Dommels YE, Martell S, Butts C, McNabb WC, Park ZA, et al. The effects of dietary curcumin and rutin on colonic inflammation and gene expression in multidrug resistance gene-deficient (mdr1a-/-) mice, a model of inflammatory bowel diseases. Br J Nutr. 2009;101(2):169–81. doi:10.1017/S0007114508009847.View ArticlePubMedGoogle Scholar
- Paturi G, Mandimika T, Butts CA, Zhu S, Roy NC, McNabb WC, et al. Influence of dietary blueberry and broccoli on cecal microbiota activity and colon morphology in mdr1a(-/-) mice, a model of inflammatory bowel diseases. Nutrition. 2012;28(3):324–30. doi:10.1016/j.nut.2011.07.018.View ArticlePubMedGoogle Scholar
- Barnett MP, Cooney JM, Dommels YE, Nones K, Brewster DT, Park Z, et al. Modulation of colonic inflammation in Mdr1a(-/-) mice by green tea polyphenols and their effects on the colon transcriptome and proteome. J Nutr Biochem. 2013;24(10):1678–90. doi:10.1016/j.jnutbio.2013.02.007.View ArticlePubMedGoogle Scholar
- Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 1993;69(2):238–49.PubMedGoogle Scholar
- Park EI, Paisley EA, Mangian HJ, Swartz DA, Wu MX, O’Morchoe PJ, et al. Lipid level and type alter stearoyl CoA desaturase mRNA abundance differently in mice with distinct susceptibilities to diet-influenced diseases. J Nutr. 1997;127(4):566–73.PubMedGoogle Scholar
- Roy NC, Barnett MPG, Knoch B, Dommels YEM, McNabb WC. Nutrigenomics applied to an animal model of Inflammatory Bowel Diseases: transcriptomic analysis of the effects of eicosapentaenoic acid- and arachidonic acid-enriched diets. Mutat Res. 2007;622(1-2):103–16.View ArticlePubMedGoogle Scholar
- Maggio-Price L, Shows D, Waggie K, Burich A, Zeng W, Escobar S, et al. Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a-/-) mice. Am J Pathol. 2002;160(2):739–51. doi:10.1016/S0002-9440(10)64894-8.View ArticlePubMedPubMed CentralGoogle Scholar
- Burich A, Hershberg R, Waggie K, Zeng W, Brabb T, Westrich G, et al. Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice. Am J Physiol Gastrointest Liver Physiol. 2001;281(3):G764–78.PubMedGoogle Scholar
- Ganesh BP, Richter JF, Blaut M, Loh G. Enterococcus faecium NCIMB 10415 does not protect interleukin-10 knock-out mice from chronic gut inflammation. Benef Microbes. 2012;3(1):43–50. doi:10.3920/BM2011.0050.View ArticlePubMedGoogle Scholar
- Steck N, Hoffmann M, Sava IG, Kim SC, Hahne H, Tonkonogy SL, et al. Enterococcus faecalis metalloprotease compromises epithelial barrier and contributes to intestinal inflammation. Gastroenterology. 2011;141(3):959–71. doi:10.1053/j.gastro.2011.05.035.View ArticlePubMedGoogle Scholar
- Wong K, Bumpstead S, Van Der Weyden L, Reinholdt LG, Wilming LG, Adams DJ, et al. Sequencing and characterization of the FVB/NJ mouse genome. Genome Biol. 2012;13(8):R72. doi:10.1186/gb-2012-13-8-r72.View ArticlePubMedPubMed CentralGoogle Scholar
- Deguchi Y, Andoh A, Inatomi O, Araki Y, Hata K, Tsujikawa T, et al. Development of dextran sulfate sodium-induced colitis is aggravated in mice genetically deficient for complement C5. Int J Mol Med. 2005;16(4):605–8.PubMedGoogle Scholar
- Bassett SA, Young W, Barnett MP, Cookson AL, McNabb WC, Roy NC. Changes in composition of caecal microbiota associated with increased colon inflammation in interleukin-10 gene-deficient mice inoculated with Enterococcus species. Nutrients. 2015;7(3):1798–816. doi:10.3390/nu7031798.View ArticlePubMedPubMed CentralGoogle Scholar
- Knoch B, Barnett MP, Zhu S, Park ZA, Nones K, Dommels YE, et al. Genome-wide analysis of dietary eicosapentaenoic acid- and oleic acid-induced modulation of colon inflammation in interleukin-10 gene-deficient mice. J Nutrigenet Nutrigenomics. 2009;2(1):9–28. doi:10.1159/000134292.View ArticlePubMedGoogle Scholar
- Lin HM, Barnett MP, Roy NC, Joyce NI, Zhu S, Armstrong K, et al. Metabolomic analysis identifies inflammatory and noninflammatory metabolic effects of genetic modification in a mouse model of Crohn’s disease. J Proteome Res. 2010;9(4):1965–75. doi:10.1021/pr901130s.View ArticlePubMedGoogle Scholar
- Russ AE, Peters JS, McNabb WC, Barnett MP, Anderson RC, Park Z, et al. Gene expression changes in the colon epithelium are similar to those of intact colon during late inflammation in interleukin-10 gene deficient mice. PLoS One. 2013;8(5):e63251. doi:10.1371/journal.pone.0063251.View ArticlePubMedPubMed CentralGoogle Scholar